Bookmark

Add to MyYahoo RSS

Incyte News

News on Incyte (Ticker: INCY) continually updated from thousands of sources around the net.

Yesterday | BioSpace

Incyte Corporation Release: Jakafi (ruxolitinib) Product Label ...

Incyte Corporation announced today that the U.S. Food & Drug Administration has approved supplemental labeling for JakafiA to include new Kaplan-Meier overall survival curves as well as additional safety and dosing information.

Comment?

Related Topix: Food and Drug Administration

Yesterday | Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

On the strength ... )--Polaris celebrated 60 years of innovation by introducing the highly anticipated PolarisA Slingshota , an awe-inspiring 3-wheel roadster that represents the future of on... )--Research and Markets has announced the addition of the "Global Ceiling Tiles --FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A ... (more)

Comment?

Related Topix: Mining, Alliance Resource Partners LP, Startups, Oak Investment Partners, Food and Drug Administration, Healthcare Law, Law

Wed Jul 23, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Gate 1 Travel, a leader in affordable and international travel, is... )--FortinetA , a global leader in high-performance network security, today announced financial results for the second quarter ended June 30, 2014.

Comment?

Related Topix: VSE, VSE Corp, Aerospace-Defense, Bay State Gas, Energy, Restaurant Management, Cheesecake Factory Incorporated The, Telecom, TESSCO Technologies

Hispanic Business

Incyte Announces Top-Line Results from RELIEF Trial of Ruxolitinib in Patients with Polycythemia Vera

Statistical significance not achieved for the primary endpoint of symptom control; positive trends in favor of ruxolitinib versus hydroxyurea observed RELIEF trial conducted in patients who were generally well-controlled on hydroxyurea but reporting continued disease-related symptoms, a different population than the pivotal Phase III RESPONSE trial ... (more)

Comment?

Related Topix: Medicine, Hydrea, Hydroxyurea (generic)

Fri Jul 18, 2014

AmericanBankingNews.com

Insider Selling: Incyte EVP Sells 8,000 Shares of Stock

Incyte EVP Richard S. Levy sold 8,000 shares of the company's stock on the open market in a transaction that occurred on Wednesday, July 16th.

Comment?

Related Topix: Stanley

Mon Jul 14, 2014

Freshnews

Incyte to Report Second Quarter 2014 Financial Results on July 31

Incyte Corporation announced today that it has scheduled its second quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, July 31, 2014.

Comment?

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

This distribution ... )--Central Desktop's SocialBridge SuiteApp for marketers and agencies centralizes work in a single platform while leveraging the accounting and job tracking capabili... )--Esker, a worldwide leader in document process automation solutions, announced today that TMC, a global, integrated media company, has named Esker on Demand ... (more)

Comment?

Related Topix: NCR, Computers

Wed Jul 09, 2014

The News Journal

Incyte Corp. announces $25M payment from Novartis

A Delaware-based pharmaceutical company announced it has earned a $25 million payout after earning approval in Japan for a drug to treat Incyte Corp. announces $25M payment from Novartis A Delaware-based pharmaceutical company announced it has earned a $25 million payout after earning approval in Japan for a drug to treat Check out this story on ... (more)

Comment?

Tue Jul 08, 2014

Pharmaceutical Processing

Incyte Get $25M Milestone Payment from Novartis after JakaviA Approval in Japan

Incyte Corporation announced today that it has earned a $25 million milestone payment from Novartis in connection with the approval of Jakavi in Japan for the treatment of patients with myelofibrosis.

Comment?

Seeking Alpha

Jakavi approval triggers milestone payment

The approval of Jakavi for the treatment of myelofibrosis by the Japanese Ministry of Health, Labor and Welfare triggers a $25M milestone payment to Incyte Corp. from collaboration partner Novartis .

Comment?

Related Topix: Biotech, Novartis

Fri Jul 04, 2014

AmericanBankingNews.com

Incyte Rating Reiterated by Zacks

's stock had its "neutral" rating reiterated by Zacks in a research note issued on Friday.

Comment?

Tue Jul 01, 2014

AmericanBankingNews.com

Incyte Receives Average Recommendation of "Buy" from Brokerages

Shares of Incyte have earned a consensus recommendation of "Buy" from the sixteen brokerages that are covering the stock, American Banking & Market News reports .

Comment?

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••